Bone Sarcomas in the Adolescent and Young Adult Population
Fig. 16.1 Proportion of major bone sarcoma groups by age (SEER, 2000–2011) Fig. 16.2 Bone incidence by type and age from SEER (2000–2011) The clinical significance of bone sarcomas in…
Fig. 16.1 Proportion of major bone sarcoma groups by age (SEER, 2000–2011) Fig. 16.2 Bone incidence by type and age from SEER (2000–2011) The clinical significance of bone sarcomas in…
Survivors of AYA cancer No history of cancer p-value Adjusted expenditures [95 % CI] Adjusted expenditures [95 % CI] All sources of payment $7,417 [6,133, 8,700] $4,247 [4,142, 4,352]…
Fig. 10.1 Age-dependent incidence of melanoma. Age-dependent incidence of in-situ and invasive melanoma (top left). Age-dependent incidence of melanoma by sex (top right). Age-dependent incidence of AYA melanoma in face/scalp/neck…
Family Family support networks Direct Indirect Direct Indirect Median $3503 $23,130 $575 $3215 Range $754–$51,906 $1259–$48,236 $6–$10,315 $58–$29,061 Reference 46 47 In Canadian dollars It has been suggested that…
© Springer International Publishing 2017Archie Bleyer, Ronald Barr, Lynn Ries, Jeremy Whelan and Andrea Ferrari (eds.)Cancer in Adolescents and Young AdultsPediatric Oncology10.1007/978-3-319-33679-4_31 31. Palliative Care Karen Wasilewski-Masker1 , Tracy Howk2 , Erin Connelly2 , Sergey Postovsky3 , Pamela Brill2 , Kate Carlson Wrammert4 and Rathi Pillai4 (1) The Aflac Cancer &…
Therapeutic exposure Potential late effect Vincristine, vinblastine Peripheral neuropathy, Raynaud’s phenomenon Corticosteroids Cataracts, osteopenia, osteoporosis, avascular necrosis Mercaptopurine Hepatic dysfunction, veno-occlusive disease Methotrexate (Systemic) osteopenia, osteoporosis, renal dysfunction, hepatic dysfunction…
Fig. 26.1 Potential problems encountered by AYA during and following treatment for cancer according to the International Classification of Functioning, Disability and Health 26.2 Body Structure and Function Impairments of…
Agent Cumulative dose associated with azoospermia Cyclophosphamide >5–7.5 g/m2 associated with abnormal semen parameters, >19 g/m2 consistently result in azoospermia Ifosfamide >60 g/m2 Procarbazine >4 g/m2 Busulfan >600 mg/m2 Melphalan…
© Springer International Publishing 2017Archie Bleyer, Ronald Barr, Lynn Ries, Jeremy Whelan and Andrea Ferrari (eds.)Cancer in Adolescents and Young AdultsPediatric Oncology10.1007/978-3-319-33679-4_23 23. Psychosocial Issues in Adolescent and Young Adult Patients and Survivors Anthony Penn1 , Aura Kuperberg2 and Brad J. Zebrack3 (1)…
Fig. 1.1 Landmark events in the development of AYA oncology in North America. CCG Children’s Cancer Group, NCI National Cancer Institute, PRG Progress Review Group, JAYAO Journal of Adolescent and…